PDK4 as a potential therapeutic target for antineutrophil cytoplasmic antibody associated glomerulonephritis
Current Proteomics · 2026-06 · 23 (3) · 100128
DOI: 10.1016/j.curpro.2026.100128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Proteomics, 2026-06. Verfasst von Aili Wang und 2 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hubei Province Natural Science Foundation.
Abstract (Originalsprache)
Background
ANCA-associated glomerulonephritis (ANCA-GN) is a severe renal manifestation of ANCA-associated vasculitis, and additional molecular markers and therapeutic hypotheses are needed.
Objectives
This study aimed to identify ferroptosis-related transcriptomic candidates in ANCA-GN, evaluate the exploratory diagnostic performance of a PDK4-containing gene signature, and investigate the potential role of PDK4 in glomerular endothelial injury.
Methods
Public transcriptomic datasets from GEO, E-MTAB-1944, and Nephroseq v5 were analyzed to identify differentially expressed ferroptosis-related genes (DE-FRGs). Functional enrichment analysis, machine-learning screening, SHAP interpretation, and diagnostic-model reanalysis were performed. Molecular docking and molecular dynamics simulations were used to explore protein-ligand interactions. PDK4 expression and endothelial injury-related effects were examined in available human tissue, experimental autoimmune vasculitis rats, and in vitro glomerular endothelial cell experiments.
Results
Eleven DE-FRGs were identified. CD44, CYBB, MT1G, and PDK4 were selected as characteristic genes, and PDK4 showed consistent downregulation in ANCA-GN public datasets. Additional diagnostic-model reanalysis showed high ranking discrimination but also indicated that threshold calibration/generalizability require caution. PDK4 was decreased in ANCA-GN kidney tissue, experimental autoimmune vasculitis rat kidneys, and injured glomerular endothelial cells. PDK4 overexpression and rosiglitazone treatment attenuated MPO-ANCA-positive IgG-induced endothelial injury markers in vitro; however, direct ferroptosis-specific assays and in vivo PDK4-mediated rosiglitazone mechanisms were not demonstrated.
Conclusions
PDK4 is a ferroptosis-related transcriptomic candidate that is decreased in ANCA-GN and may participate in glomerular endothelial injury. The PDK4-containing diagnostic signature remains exploratory and requires prospective validation, calibration, and mechanistic testing.
Förderung
- Hubei Province Natural Science Foundation
Zitieren
APA
Wang, A., Huang, L., & Liu, Q. (2026). PDK4 as a potential therapeutic target for antineutrophil cytoplasmic antibody associated glomerulonephritis. Current Proteomics, 23(3), 100128. https://doi.org/10.1016/j.curpro.2026.100128
Vancouver
Wang A, Huang L, Liu Q. PDK4 as a potential therapeutic target for antineutrophil cytoplasmic antibody associated glomerulonephritis. Current Proteomics. 2026;23(3):100128. doi:10.1016/j.curpro.2026.100128
BibTeX
@article{Wang2026,
author = {Wang, Aili and Huang, Luyan and Liu, Qingquan},
title = {PDK4 as a potential therapeutic target for antineutrophil cytoplasmic antibody associated glomerulonephritis},
journal = {Current Proteomics},
year = {2026},
volume = {23},
number = {3},
pages = {100128},
doi = {10.1016/j.curpro.2026.100128}
}
EUVIMED